AhR activation has been found to promote the trans-differentiation of antigen-presenting cells (APCs), such as dendritic cells (DCs) and macrophages, toward a more tolerogenic or tumor-permissive phenotype, resulting in the generation of immune-suppressive regulatory T (Tregs) cells. The gene discussed is AHR; the disease is neoplasm.